• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[可穿戴式心脏复律除颤器作为诊断工具:远程监测日常实践中的病例报告]

[The wearable cardioverter defibrillator as diagnostic tool : Case report from remote monitoring daily practice].

作者信息

Pulickal Tobyson, Helms Thomas M, Perings Christian A

机构信息

Katholisches Klinikum Lünen / Werne St.-Marien-Hospital Lünen, Medizinische Klinik 1, Lünen, Deutschland.

Deutsche Stiftung für chronisch Kranke, Fürth, Deutschland.

出版信息

Herzschrittmacherther Elektrophysiol. 2021 Jun;32(2):264-268. doi: 10.1007/s00399-021-00769-0. Epub 2021 May 12.

DOI:10.1007/s00399-021-00769-0
PMID:33982175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8114974/
Abstract

Telemedical care can point out new applications of already established therapeutics such as a wearable cardioverter-defibrillator (WCD) and improve the quality of care for chronically ill patients with heart failure through improved management of data derived from this device. The current case report describes the clinical course of a 71-year-old man, who was treated with a WCD in accordance with the current guidelines until a final decision was made about ICD implantation, after acute cardiac decompensation and lately diagnosed severe decrease of left ventricular function in the context of ischaemic cardiomyopathy. The data collected by the WCD were evaluated in a structured way via a telemedicine centre (TMC) and recurrence of the previously known paroxysmal atrial fibrillation (AF) was discovered. This made it possible to treat the paroxysmal AF, before cardiac decompensation happened again by adjusting the medication and early initiation of pulmonary vein isolation (PVI). This case exemplifies the usefulness of structured telemedical intervention, which makes it possible to meaningfully supplement established concepts of patient care, improve existing concepts and significantly improve patient care.

摘要

远程医疗护理可以指出已有的治疗方法(如可穿戴式心脏复律除颤器(WCD))的新应用,并通过改善从该设备获取的数据管理,提高慢性心力衰竭患者的护理质量。本病例报告描述了一名71岁男性的临床病程,该患者在急性心脏失代偿和近期诊断为缺血性心肌病导致左心室功能严重下降后,根据当前指南接受WCD治疗,直至最终决定是否植入植入式心脏转复除颤器(ICD)。通过远程医疗中心(TMC)以结构化方式对WCD收集的数据进行评估,发现了先前已知的阵发性心房颤动(AF)复发。这使得在再次发生心脏失代偿之前,通过调整药物治疗和早期启动肺静脉隔离(PVI)来治疗阵发性AF成为可能。该病例例证了结构化远程医疗干预的实用性,它能够有意义地补充既定的患者护理概念,改进现有概念并显著改善患者护理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ab4/8166737/628270122028/399_2021_769_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ab4/8166737/76fb6211eb85/399_2021_769_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ab4/8166737/4e30c14c5829/399_2021_769_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ab4/8166737/628270122028/399_2021_769_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ab4/8166737/76fb6211eb85/399_2021_769_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ab4/8166737/4e30c14c5829/399_2021_769_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ab4/8166737/628270122028/399_2021_769_Fig3_HTML.jpg

相似文献

1
[The wearable cardioverter defibrillator as diagnostic tool : Case report from remote monitoring daily practice].[可穿戴式心脏复律除颤器作为诊断工具:远程监测日常实践中的病例报告]
Herzschrittmacherther Elektrophysiol. 2021 Jun;32(2):264-268. doi: 10.1007/s00399-021-00769-0. Epub 2021 May 12.
2
Effective treatment of electrical storm by a wearable cardioverter defibrillator in a patient with severely impaired left ventricular function after myocardial infarction: a case report.心梗后严重左心室功能受损患者中可穿戴式除颤器治疗电风暴的疗效:病例报告。
J Med Case Rep. 2021 May 17;15(1):243. doi: 10.1186/s13256-021-02833-2.
3
Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.植入式心脏复律除颤器治疗的风险分层:可穿戴式心脏除颤器的作用。
Eur Heart J. 2013 Aug;34(29):2230-42. doi: 10.1093/eurheartj/eht167. Epub 2013 May 31.
4
[Wearable defibrillator : Current evidence].[可穿戴式除颤器:当前证据]
Herzschrittmacherther Elektrophysiol. 2018 Dec;29(4):362-368. doi: 10.1007/s00399-018-0601-z. Epub 2018 Oct 24.
5
Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland.在瑞士的一家三级保健医院和一家地区医院使用可穿戴除颤器期间和之后的结果。
Swiss Med Wkly. 2019 Nov 10;149:w20136. doi: 10.4414/smw.2019.20136. eCollection 2019 Nov 4.
6
Experience with the wearable cardioverter-defibrillator in older patients: Results from the Prospective Registry of Patients Using the Wearable Cardioverter-Defibrillator.老年患者穿戴式除颤器的应用经验:来自穿戴式除颤器患者前瞻性注册研究的结果。
Heart Rhythm. 2018 Sep;15(9):1379-1386. doi: 10.1016/j.hrthm.2018.04.014. Epub 2018 Apr 18.
7
Multiparameter Monitoring with a Wearable Cardioverter Defibrillator.可穿戴式除颤器的多参数监测。
Sensors (Basel). 2021 Dec 21;22(1):22. doi: 10.3390/s22010022.
8
Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.心力衰竭患者的治疗优化:可穿戴式心脏复律除颤器在实际应用中的作用。
BMC Cardiovasc Disord. 2018 Mar 15;18(1):52. doi: 10.1186/s12872-018-0790-8.
9
Long-term use of the wearable cardioverter defibrillator in patients with explanted ICD.已植入式心律转复除颤器患者中可穿戴式除颤器的长期使用。
Int J Cardiol. 2018 Dec 1;272:179-184. doi: 10.1016/j.ijcard.2018.08.017. Epub 2018 Aug 10.
10
Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.可穿戴式心脏复律除颤器支持的强化心力衰竭治疗优化以避免过早植入植入式心脏复律除颤器——PROLONG研究
J Am Heart Assoc. 2017 Jan 17;6(1):e004512. doi: 10.1161/JAHA.116.004512.

引用本文的文献

1
Multiparameter Monitoring with a Wearable Cardioverter Defibrillator.可穿戴式除颤器的多参数监测。
Sensors (Basel). 2021 Dec 21;22(1):22. doi: 10.3390/s22010022.

本文引用的文献

1
Mortality and morbidity 1 year after stopping a remote patient management intervention: extended follow-up results from the telemedical interventional management in patients with heart failure II (TIM-HF2) randomised trial.停止远程患者管理干预措施 1 年后的死亡率和发病率:心力衰竭远程医疗干预管理 II 试验(TIM-HF2)的扩展随访结果。
Lancet Digit Health. 2020 Jan;2(1):e16-e24. doi: 10.1016/S2589-7500(19)30195-5. Epub 2019 Dec 12.
2
Impact of wearable cardioverter-defibrillator compliance on outcomes in the VEST trial: As-treated and per-protocol analyses.可穿戴式除颤器依从性对 VEST 试验结果的影响:按治疗分析和意向性分析。
J Cardiovasc Electrophysiol. 2020 May;31(5):1009-1018. doi: 10.1111/jce.14404. Epub 2020 Mar 3.
3
[Position paper telemonitoring : From the Nucleus Members of the AG33 Telemonitoring of the DGK and associated members].[立场文件:远程监测——来自德国心脏病学会AG33远程监测核心成员及相关成员]
Herzschrittmacherther Elektrophysiol. 2019 Sep;30(3):287-297. doi: 10.1007/s00399-019-0630-2.
4
Effectiveness of telemedicine systems for adults with heart failure: a meta-analysis of randomized controlled trials.远程医疗系统对心力衰竭成人有效性的荟萃分析:随机对照试验研究。
Heart Fail Rev. 2020 Mar;25(2):231-243. doi: 10.1007/s10741-019-09801-5.
5
Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death: A Systematic Review and Meta-Analysis.可穿戴式心脏除颤器治疗预防心源性猝死:系统评价和荟萃分析。
JACC Clin Electrophysiol. 2019 Feb;5(2):152-161. doi: 10.1016/j.jacep.2018.11.011. Epub 2019 Jan 30.
6
Achieving Guideline-Directed Heart Rate ControlEarly Posthospitalization.实现指南导向的心率控制:住院后早期。
Am J Cardiol. 2019 Apr 1;123(7):1096-1100. doi: 10.1016/j.amjcard.2018.12.032. Epub 2019 Jan 4.
7
[Basic structural features of a cardiac telemedicine center for patients with heart failure and implanted devices, cardiac arrhythmias, and increased risk of sudden cardiac death : Recommendations of the working group 33 Telemonitoring of the German Cardiac Society].[德国心脏病学会第33工作组远程监测:心力衰竭、植入式设备、心律失常及心脏性猝死风险增加患者的心脏远程医疗中心基本结构特征建议]
Herzschrittmacherther Elektrophysiol. 2019 Mar;30(1):136-142. doi: 10.1007/s00399-018-0606-7. Epub 2019 Jan 14.
8
Wearable Cardioverter-Defibrillator after Myocardial Infarction.心肌梗死后的可穿戴式心脏除颤器。
N Engl J Med. 2018 Sep 27;379(13):1205-1215. doi: 10.1056/NEJMoa1800781.
9
Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial.远程医疗介入管理对心力衰竭患者的疗效(TIM-HF2):一项随机、对照、平行组、非盲试验。
Lancet. 2018 Sep 22;392(10152):1047-1057. doi: 10.1016/S0140-6736(18)31880-4. Epub 2018 Aug 25.
10
Heart rate, beta-blocker use, and outcomes of heart failure with reduced ejection fraction.心率、β受体阻滞剂的使用与射血分数降低的心力衰竭结局
Eur Heart J Cardiovasc Pharmacother. 2019 Jan 1;5(1):3-11. doi: 10.1093/ehjcvp/pvy011.